10 "

: Revlimid ® 10 Mg. ?  »
|
-

PER OS

Capsules

REVLIMID is indicated for 1. Treatment of patients with transfusion-dependent anemia due to low- or intermediate - 1 - risk myelodysplastic syndromes associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormality. 2. In combination with dexamethasone treatment of multiple myeloma patient who have received at least one prior therapy.3. Mantle cell lymphoma (MCL) whose disease has relapsed or progressed after two prior therapies, one of which included bortezomib

140 46 31661 11

Celgene Europe Ltd, Uk

04/2014 - 04/2024

.
, .
.
/
Lenalidomide 10 MG
Blister pvc/pctfe 21 x CAPSULES 36

*

*

 

.

 
" !
 

- !
:  »
529
, -